Oncogene 2012. 20. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C, Croce CM: learn more MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007, 297:1901–1908.PubMedCrossRef 21. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65:7065.PubMedCrossRef 22. Yanaihara N, Caplen N, Bowman

E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9:189–198.PubMedCrossRef 23. Li X, Zhang Y, Ding J, Wu K, Fan D: Survival prediction BVD-523 nmr of gastric cancer by a seven-microRNA signature. Gut 2010, 59:579–585.PubMedCrossRef 24. Zhang J, Yang Y, Yang T, Liu Y, Li A, Fu S, Wu M, Pan Z, Zhou W: microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br J Cancer 2010, 103:1215–1220.PubMedCrossRef 25. Calin GA, Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 2006, 6:857–866.PubMedCrossRef 26. Matsubara H, Takeuchi T, Nishikawa E, Yanagisawa K, Hayashita Y, Ebi H, Yamada H, Suzuki M, Nagino M, Nimura Y: Apoptosis induction by antisense oligonucleotides

against miR-17–5p and miR-20a in lung cancers Crenigacestat nmr overexpressing miR-17–92. Oncogene 2007, 26:6099–6105.PubMedCrossRef 27. Sieghart W, Losert D, Strommer S, Cejka D, Schmid K, Rasoul-Rockenschaub S, Bodingbauer M, Crevenna

R, Monia BP, Peck-Radosavljevic M: Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy. J Hepatol 2006, 44:151–157.PubMedCrossRef 28. Schulze-Bergkamen H, Fleischer B, Schuchmann M, Weber A, Weinmann A, Krammer P, Galle P: Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction. BMC Cancer 2006, 6:232.PubMedCrossRef 29. Wuilleme-Toumi S, Robillard Leukocyte receptor tyrosine kinase N, Gomez P, Moreau P, Le Gouill S, Avet-Loiseau H, Harousseau J, Amiot M, Bataille R: Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival. Leukemia 2005, 19:1248–1252.PubMedCrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions MQF and CBH participated in the study design, conducted the real-time PCR assays and drafted the manuscript; YG carried out the proliferation and flow cytometry analysis; YX carried out the luciferase reporter and western bolt assay; JXS conducted immunohistochemical staining; LZ conceived of the study, and participated in its design and coordination, and reviewed the manuscript. All authors read and approved the final manuscript.”
“Background Human glioblastomas are the most common primary tumors of the central nervous system [1].